The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
February 22nd 2024
Precision oncology represents an evolution in therapeutic practice.
No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens
December 8th 2023Study results indicate insignificant differences between PFS and OS in patients with HR[+]/HER2[-] breast cancer who received either palbociclib-letrozole or palbociclib-fulvestrant treatment.
Read More
Study Finds Inavolisib Combination Treatment Improved PFS in Patients With Breast Cancer
December 5th 2023In the first-line setting, inavolisib plus palbociclib and fulvestrant improved PFS in patients with HR-positive breast cancers; however, further research is needed to understand the trends in OS.
Read More